InsiderClue
Insiders · Profile

WELTERS ANTHONY

Director at Gilead Sciences · Director at Loews · Director at Carlyle · and 2 more. Filing since 23 Feb 2009. CIK 0001213307

GILD Gilead Sciences Director · 1 trade L Loews Corporation Director · 7 trades CG Carlyle Group Inc. Director · 1 trade WST West Pharmaceutical Services Director · 3 trades UNH UnitedHealth Group EVP, UnitedHealth Group · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
GILD Gilead Sciences
26 Aug 2026
Director
Sold on a plan
18,000
$2.68M
58.3%
L Loews Corporation
3 Mar 2025
Director
Sold on a plan
1,197
$103.98K
10.8%
L Loews Corporation
2 Dec 2024
Director
Sold on a plan
1,146
$99.48K
10.4%
L Loews Corporation
3 Sep 2024
Director
Sold on a plan
1,088
$88.57K
10.0%
L Loews Corporation
3 Jun 2024
Director
Sold on a plan
963
$73.00K
8.9%
L Loews Corporation
1 Mar 2024
Director
Sold on a plan
951
$71.33K
10.5%
L Loews Corporation
1 Dec 2023
Director
Sold on a plan
715
$50.16K
8.1%
CG Carlyle Group Inc.
2 Dec 2015
Director
Bought
25,000
$444.29K
937%
L Loews Corporation
2 Dec 2015
Director
Bought
3,000
$114.93K
opened
WST West Pharmaceutical Services
12 Aug 2013
Director
Sold, plan not stated
19,200
$1.51M
50.6%
UNH UnitedHealth Group
23 Apr 2012
EVP, UnitedHealth Group
Sold, plan not stated
90,571
$5.35M
41.6%
UNH UnitedHealth Group
8 Mar 2012
EVP, UnitedHealth Group
Sold, plan not stated
30,000
$1.67M
19.5%
WST West Pharmaceutical Services
23 Feb 2012
Director
Sold, plan not stated
9,000
$383.53K
38.1%
UNH UnitedHealth Group
13 Feb 2012
EVP, UnitedHealth Group
Sold, plan not stated
76,000
$4.07M
33.1%
UNH UnitedHealth Group
14 Dec 2011
EVP, UnitedHealth Group
Sold, plan not stated
18,254
$879.14K
13.7%
UNH UnitedHealth Group
26 Jul 2011
EVP, UnitedHealth Group
Sold, plan not stated
1,225
$63.08K
1.1%
UNH UnitedHealth Group
25 Jul 2011
EVP, UnitedHealth Group
Sold, plan not stated
19,800
$1.03M
14.8%
UNH UnitedHealth Group
9 Dec 2010
EVP & Pres Public & Sr Mkt Grp
Sold, plan not stated
97,500
$3.56M
51.1%
WST West Pharmaceutical Services
23 Feb 2009
Director
Sold, plan not stated
5,250
$162.23K
42.2%
19 decisions on file.